M. Hernández

The EUROclass trial: defining subgroups in common variable immunodeficiency

Claudia Wehr, Teemu Kivioja, C. Schmitt et al. · Blood · 2007 · 848 citations · Full text

Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities.

W. Lledo, M. Hernández, E. Lopez et al. · MMWR Morbidity and Mortality Weekly Report · 2009 · 391 citations

Antimicrobial Susceptibility, Antibiotics, Antimicrobial Stewardship +9

Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution

Edoardo Caronna, Alejandro Ballvé, Arnau Llauradó et al. · Cephalalgia · 2020 · 228 citations · Full text

Clinical Tuberculosis in 2 of 3 Siblings with Interleukin-12 Receptor  1 Deficiency

Isabel Caragol, Claire Fieschi, J. Feinberg et al. · Clinical Infectious Diseases · 2003 · 116 citations · Full text

Development of a Common Variable Immunodeficiency in IgA-Deficient Patients

Teresa Español, Martin Catala, M. Hernández et al. · Clinical Immunology and Immunopathology · 1996 · 105 citations

Primary Immunodeficiency, Autoimmune Disease, Immunodeficiencies +7